Mitochondrial microheteroplasmy and a theory of aging and age-related disease
Rafal M Smigrodzki1, Shaharyar M Khan
1Gencia Corporation, Charlottesville, Virginia 22903, USA. rafal@genciabiotech.com
Abstract:
We implicate a recently described form of mitochondrial mutation, mitochondrial microheteroplasmy, as a candidate for the principal component of aging. Microheteroplasmy is the presence of hundreds of independent mutations in one organism, with each mutation usually found in 1-2% of all mitochondrial genomes. Despite the low abundance of single mutations, the vast majority of mitochondrial genomes in all adults are mutated. This mutational burden includes inherited mutations, de novo germline mutations, as well as somatic mutations acquired either during early embryonic development or later in adult life. We postulate that microheteroplasmy is sufficient to explain the pathomechanism of several age-associated diseases, especially in conditions with known mitochondrial involvement, such as diabetes (DM), cardiovascular disease, Parkinson's disease (PD), and Alzheimer's disease (AD) and cancer. The genetic properties of microheteroplasmy reconcile the results of disease models (cybrids, hypermutable PolG variants and mitochondrial toxins), with the relatively low levels of maternal inheritance in the aforementioned diseases, and provide an explanation of their delayed, progressive course.
Insights
Mitochondrial microheteroplasmy, the presence of numerous low-abundance mutations, is proposed as a key driver of aging. This widespread mutational burden in mitochondrial genomes explains age-associated diseases and their progressive nature.
Area of Science:
- Mitochondrial biology
- Aging research
- Genetics
Background:
- Mitochondrial mutations accumulate with age.
- Mitochondrial microheteroplasmy involves hundreds of mutations, each at low abundance (1-2%).
- Despite low individual mutation levels, most adult mitochondrial genomes are affected.
Purpose of the Study:
- To identify the principal component of aging.
- To investigate mitochondrial microheteroplasmy as a candidate for aging.
- To explain the pathomechanism of age-associated diseases with mitochondrial involvement.
Main Methods:
- Analysis of mitochondrial mutation burden.
- Postulation of microheteroplasmy's role in aging and disease.
- Reconciliation of disease models with genetic properties of microheteroplasmy.
Main Results:
- Mitochondrial microheteroplasmy is present in the vast majority of adult mitochondrial genomes.
- This mutational burden includes inherited, de novo, and somatic mutations.
- Microheteroplasmy can explain the pathomechanism of age-associated diseases like diabetes, cardiovascular disease, Parkinson's, Alzheimer's, and cancer.
Conclusions:
- Mitochondrial microheteroplasmy is a strong candidate for the principal component of aging.
- It explains the delayed and progressive course of several age-associated diseases.
- It reconciles findings from various disease models with observed inheritance patterns.
Related Concept Videos
Mitochondria
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Animal Mitochondrial Genetics
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
